Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
High-Flying Picks: 3 Nasdaq Stocks to Buy Amid the Record-Breaking Rally
06:15am, Monday, 03'rd Jun 2024
With the Nasdaq keeping up its record of reaching new heights in May, investors are wondering which stocks to buy amidst the record-breaking environment. The artificial intelligence (AI) rally continu
These two ETFs distribute monthly payouts and have high yields. Covered calls provide consistent income in a challenging market period.
1 Ultra-High-Yielding ETF I Can't Wait to Buy More of in June
05:39am, Sunday, 02'nd Jun 2024
JPMorgan Nasdaq Equity Premium ETF offers a high-yielding payout and equity upside potential. It generates income by writing call options on the Nasdaq-100.
COPENHAGEN, Denmark, and MAINZ, Germany, June 1, 2024 — Genmab A/S (Nasdaq: GMAB, “Genmab”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced initial data from the ongoing Phase 2 t
$10,000 in This High-Yield Vanguard ETF Incurs a Mere $10 Annual Fee, and It Has Beaten the S&P 500 and Nasdaq Composite in 2024
04:20am, Saturday, 01'st Jun 2024
Utilities have been one of the best-performing sectors so far this year. The Vanguard Utilities ETF is a low-cost way to get exposure to the sector while earning a 3.3% yield.
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:45pm, Friday, 31'st May 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on May 31, 2024 (the “Grant Date”) th
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05:41pm, Friday, 31'st May 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of RiskOn International, Inc. RiskOn International, Inc.'s securities were sus
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 31'st May 2024
BOSTON, May 31, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medi
Correction Collection: 3 Value Stocks to Buy When the Nasdaq Nosedives
01:05pm, Friday, 31'st May 2024
Is this the beginning of the end? After a tremendous run higher over the last year and a half, the Nasdaq exchange is pulling back from recent highs.
Astra Space Inc. Receives and Subsequently Cures Deficiency Notice from Nasdaq Due to Late 10-Q Filing
09:00am, Friday, 31'st May 2024
ALAMEDA, Calif.--(BUSINESS WIRE)---- $ASTR #adastra--Astra Space, Inc. (“Astra”) announced that on May 22, 2024, it received a deficiency notice from Nasdaq indicating that, because Astra did not
The Real Good Food Company Receives Nasdaq Notice Regarding Filing Requirements
08:31am, Friday, 31'st May 2024
CHERRY HILL, N.J., May 31, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated f
The tech sector is up nearly threefold over the last five years. There's a lot more to this group than just semiconductor and software stocks.
Maxeon Solar Technologies Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
08:00am, Friday, 31'st May 2024
SINGAPORE , May 31, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) (the "Company"), a global leader in solar innovation and channels, announced that the Company has regained compl
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
08:00am, Friday, 31'st May 2024
SAN DIEGO and TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing hig
